tirzepatide sales 2024 Weight-loss drug drives Eli Lilly to raise forecast by $2 billion Eli Lilly's Mounjaro sales projected

Chae H, Ryu M-H, Ma J, Beck M, Kang Y-K

Errors in unit conversion during tapering can lead to inadvertent dose changes that confuse the tapering process

The irony is that most people that quit keto dont actually eat true keto macros which are: Fat: 7080% of total calories Protein: 2025% Carbohydrates: 510% (typically 2050g net carbs/day) These macros even if fat is reduced and protein increased as in ultra low carb body comp diets are still unsustainable as a lifestyle plan for most people / especially if they train for speed and strength Metabolic health is the new trend, keto just got a rebrand

This is because both of these muscle growth peptides help increase growth hormone (GH) production, which is important for the development of skeletal muscle tissue

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with a slightly different mechanism

In clinical studies, Semaglutide is shown to help patients lose an average of 20% weight*